Latest Options Offer News

Andromeda Metals has successfully raised $5 million through a heavily subscribed placement, positioning the company to advance its flagship Great White Project and promising HPA initiative.

Celsius Resources plans to issue additional free-attaching options to investors in its Tranche 2 Placement, aiming to bolster support amid challenging geopolitical and economic conditions. These options, exercisable at a nominal price, await shareholder approval and ASX listing conditions.

Nanoveu Limited has launched a $2.7 million capital raising via a share placement and a substantial options offer, pending shareholder approval for securities issued to its Executive Chairman. The prospectus outlines key risks and the impact on the company’s capital structure.

Western Yilgarn Limited has successfully closed its non-renounceable Entitlement and Priority Option Offers, raising nearly A$54,000 through the issue of new options to shareholders.

Enlitic, Inc. has launched a two-tranche institutional placement to raise A$10 million, underpinning its strategic collaboration with GE HealthCare and fueling expansion in AI-enabled medical imaging data migration.

Enlitic has formalised a binding MOU with GE HealthCare to deliver multi-million-dollar migration services, contingent on raising A$10 million through a new capital placement. This partnership and funding round mark a pivotal step in Enlitic’s growth strategy within AI-driven medical imaging.

Evion Group has marked a key milestone with its first expandable graphite shipment from its India joint venture, while progressing critical permitting for its flagship Maniry Graphite Project in Madagascar. The company also secured $2 million in funding to support expansion and development.

Resource Base Limited has bolstered its portfolio with two new tenements in the Gawler Craton, South Australia, while managing a modest cash reserve of $0.93 million and raising $45,300 through a loyalty option offer.

Infinity Mining Limited reported a challenging quarter with net cash outflows from operations and investing, but bolstered its liquidity through a $1.87 million equity raise and plans to divest Western Australian projects.

MinRex Resources reports promising gold and silver assay results from its Sunny Corner Project in NSW and secures a strategic farm-in option over the Fraser Range Copper-Gold Project in WA, underpinning its growth ambitions.

Paradigm Biopharmaceuticals has secured ethics approval and appointed a CRO to launch its global phase 3 trial for injectable Pentosan Polysulfate Sodium in knee osteoarthritis, while initiating a substantial capital raising program.

Zeus Resources reports strong progress on its Casablanca Antimony Project acquisition in Morocco, highlighted by exceptional assay results and expanded mineralisation. Concurrently, the company secures a new South Australian tenement for critical minerals and divests its Mortimer Hills Project with royalty upside.